Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fighting cancer with aspirin

04.10.2006
Aspirin has cancer-fighting effects that extend beyond its already understood abilities, report British scientists, who believe that their discovery points the way to the development of new drugs.

In addition to its known ability to block an enzyme called cyclooxygenase (COX), aspirin also reduces the formation of blood vessels that fuel developing tumors, it is reported in the current (October) edition of a leading scientific journal.

Without new blood vessels - formed through a process called angiogenesis - tumors cannot grow beyond the size of a pea. With this information, researchers can pursue new lines of investigation that could ultimately yield an entirely new type of cancer-fighting drug.

In the study, Dr Helen Arthur and colleagues at Newcastle University Medical School show that salicylate, an ancient remedy found in plants and closely related to aspirin, also reduces the formation of new blood vessels, an important part of tumor development.

The findings, which appear in the October 2006 issue of The Journal of the Federation of American Societies for Experimental Biology (FASEB), provides important clues to how aspirin works in cancer and in inflammation.

'Aspirin has always been touted as a wonder drug,' said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal, 'and this study shows that we are still learning about the many actions of this amazing drug.'

Dr Arthur said: 'We know from previous studies that low doses of aspirin taken over long periods can reduce the risk of cancer - by as much as 50 per cent in the case of bowel cancer.

'Aspirin seems to work against tumour formation in several ways, one of which is to restrict the blood supply. Tumours attract a blood supply by releasing growth factors that cause nearby blood vessels to grow into the tumour.

'We conducted experiments which involved applying various doses of aspirin to cells, which normally line the inside of blood vessels.

'Our experiments showed that low doses of aspirin had an effect on these cells which tended to cancel out the effect of the growth factors from the tumours.

She added: 'High doses of aspirin are toxic and we would like to stress that anyone suffering from cancer should not take aspirin unless they are advised to do so by a doctor.'

Dr Helen Arthur | alfa
Further information:
http://www.ncl.ac.uk

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Speed data for the brain’s navigation system

06.12.2016 | Health and Medicine

What happens in the cell nucleus after fertilization

06.12.2016 | Life Sciences

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>